Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer

[1]  H. Kuwano,et al.  Inverse Correlation Between Expression Levels of p 27 and the Ubiquitin Ligase Subunit Skp 2 in Early Esophageal Squamous Cell Carcinoma , 2009 .

[2]  K. Nakayama,et al.  Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1–S transition , 2008, Oncogene.

[3]  J. Yates,et al.  Plk1- and β-TrCP–dependent degradation of Bora controls mitotic progression , 2008, The Journal of cell biology.

[4]  N. Lehman,et al.  Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma , 2008, Modern Pathology.

[5]  Marco Foiani,et al.  Regulation of DNA repair throughout the cell cycle , 2008, Nature Reviews Molecular Cell Biology.

[6]  Anastasis Stephanou,et al.  ERK and the F-box Protein βTRCP Target STAT1 for Degradation* , 2008, Journal of Biological Chemistry.

[7]  Yang Shi,et al.  SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradation , 2008, Nature.

[8]  Timothy Cardozo,et al.  Control of chromosome stability by the β-TrCP–REST–Mad2 axis , 2008, Nature.

[9]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[10]  L. Nie,et al.  Ubiquitination and Degradation of Tal1/SCL Are Induced by Notch Signaling and Depend on Skp2 and CHIP* , 2008, Journal of Biological Chemistry.

[11]  K. Nakayama,et al.  SCFβTrCP1 Activates and Ubiquitylates TAp63γ* , 2008, Journal of Biological Chemistry.

[12]  E. Lam,et al.  Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells , 2008, Oncogene.

[13]  R. Knight,et al.  ERK AND THE E3 UBIQUITIN LIGASE  TRCP TARGETS STAT1 FOR DEGRADATION , 2008 .

[14]  L. Chiriboga,et al.  Alterations in the expression of PDCD4 in ductal carcinoma of the breast. , 2007, Oncology reports.

[15]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[16]  M. Kitagawa,et al.  Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. , 2007, Cancer research.

[17]  M. Pagano,et al.  JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes , 2007, Nature.

[18]  H. Allgayer,et al.  Loss of programmed cell death 4 expression marks adenoma‐carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer , 2007, Cancer.

[19]  Han Liu,et al.  Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions. , 2007, Genes & development.

[20]  Hanspeter Herzel,et al.  β-TrCP1-Mediated Degradation of PERIOD2 Is Essential for Circadian Dynamics , 2007, Journal of biological rhythms.

[21]  M. Pagano,et al.  APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. , 2007, Molecular cell.

[22]  M. Yaffe,et al.  TAZ Promotes PC2 Degradation through a SCFβ-Trcp E3 Ligase Complex , 2007, Molecular and Cellular Biology.

[23]  P. van Kerkhof,et al.  The Ubiquitin Ligase SCF(βTrCP) Regulates the Degradation of the Growth Hormone Receptor* , 2007, Journal of Biological Chemistry.

[24]  Bernard Ducommun,et al.  CDC25 phosphatases in cancer cells: key players? Good targets? , 2007, Nature Reviews Cancer.

[25]  J. Stewart,et al.  CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms. , 2007, Blood.

[26]  Jennifer B. Old,et al.  Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis , 2007, The EMBO journal.

[27]  Michele Pagano,et al.  SCFFbxl3 Controls the Oscillation of the Circadian Clock by Directing the Degradation of Cryptochrome Proteins , 2007, Science.

[28]  R. Tibshirani,et al.  Tumorigenesis and Neoplastic Progression Oncogenic Regulators and Substrates of the Anaphase Promoting Complex / Cyclosome Are Frequently Overexpressed in Malignant Tumors , 2007 .

[29]  Naoshi Nishida,et al.  High copy amplification of the aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers , 2007, Cancer biology & therapy.

[30]  K. Basso,et al.  Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes , 2007, Genes, chromosomes & cancer.

[31]  M. Herlyn,et al.  Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cells , 2007, Oncogene.

[32]  A. Aplin,et al.  Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells , 2007, Oncogene.

[33]  W. Park,et al.  Somatic mutations of the β‐TrCP gene in gastric cancer , 2007 .

[34]  M. Barbacid,et al.  Cell cycle kinases in cancer. , 2007, Current opinion in genetics & development.

[35]  D. Virshup,et al.  Post-translational modifications regulate the ticking of the circadian clock , 2007, Nature Reviews Molecular Cell Biology.

[36]  J. Stewart,et al.  CKS 1 B , overexpressed in aggressive disease , regulates multiple myeloma growth and survival through SKP 2-and p 27 Kip 1-dependent and-independent mechanisms , 2007 .

[37]  M. Yaffe,et al.  TAZ Promotes PC 2 Degradation through a SCF-Trcp E 3 Ligase Complex † , 2007 .

[38]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[39]  Michele Pagano,et al.  S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth , 2006, Science.

[40]  H. Zhang,et al.  Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma , 2006, Oncogene.

[41]  James M. Roberts,et al.  Testing the importance of p27 degradation by the SCFskp2 pathway in murine models of lung and colon cancer , 2006, Proceedings of the National Academy of Sciences.

[42]  M. Kitagawa,et al.  Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination. , 2006, Cancer research.

[43]  G. Scambia,et al.  RB family members as predictive and prognostic factors in human cancer , 2006, Oncogene.

[44]  D. Hershko,et al.  Prognostic role of p27Kip1 deregulation in colorectal cancer , 2006, Cancer.

[45]  L. Moro,et al.  Up-regulation of Skp2 after Prostate Cancer Cell Adhesion to Basement Membranes Results in BRCA2 Degradation and Cell Proliferation* , 2006, Journal of Biological Chemistry.

[46]  Jiri Bartek,et al.  Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. , 2006, Molecular cell.

[47]  Michele Pagano,et al.  SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. , 2006, Molecular cell.

[48]  S. Majumder.  REST in good times and bad: roles in tumor suppressor and oncogenic activities. , 2006, Cell cycle.

[49]  S. Kondo,et al.  Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. , 2006, Journal of dermatological science.

[50]  H. Kreipe,et al.  Prognostic impact of Skp2 and p27 in human breast cancer , 2006, Breast Cancer Research and Treatment.

[51]  Jinjuan Yao,et al.  The ETS Protein MEF Is Regulated by Phosphorylation-Dependent Proteolysis via the Protein-Ubiquitin Ligase SCFSkp2 , 2006, Molecular and Cellular Biology.

[52]  M. Pagano,et al.  Stabilizers and destabilizers controlling cell cycle oscillators. , 2006, Molecular cell.

[53]  Yasuo Watanabe,et al.  Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. , 2006, Oncology reports.

[54]  M. Hung,et al.  Degradation of Mcl-1 by β-TrCP Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and Chemosensitization , 2006, Molecular and Cellular Biology.

[55]  S. Fuchs,et al.  Stabilization of prolactin receptor in breast cancer cells , 2006, Oncogene.

[56]  T. Utsunomiya,et al.  Significance of skp2 expression in primary breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  Yun-Wei Lin,et al.  Cooperation of ERK and SCFSkp2 for MKP-1 Destruction Provides a Positive Feedback Regulation of Proliferating Signaling* , 2006, Journal of Biological Chemistry.

[58]  Y. Liu,et al.  [Correlation of Skp2 expression in gastric carcinoma to expression of P27 and PTEN]. , 2006, Ai zheng = Aizheng = Chinese journal of cancer.

[59]  M. Kitagawa,et al.  Degradation of Tob 1 Mediated by SCFSkp 2-Dependent Ubiquitination , 2006 .

[60]  T. Utsunomiya,et al.  Significance of Skp 2 Expression in Primary Breast Cancer , 2006 .

[61]  Yasuo Watanabe,et al.  Clinical significance of Skp 2 expression , alone and combined with Jab 1 and p 27 in epithelial ovarian tumors , 2006 .

[62]  M. Arsura,et al.  Nuclear factor-κB and liver carcinogenesis , 2005 .

[63]  Y. Liu,et al.  Relation of overexpression of S phase kinase-associated protein 2 with reduced expression of p27 and PTEN in human gastric carcinoma. , 2005, World journal of gastroenterology.

[64]  T. Yoshimine,et al.  Overexpressed Skp2 within 5p amplification detected by array‐based comparative genomic hybridization is associated with poor prognosis of glioblastomas , 2005, Cancer science.

[65]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[66]  Avram Hershko,et al.  The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture). , 2005, Angewandte Chemie.

[67]  J. Shaughnessy.  Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27 Kip1 and an aggressive clinical course in multiple myeloma , 2005, Hematology.

[68]  High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma , 2005, Journal of Cancer Research and Clinical Oncology.

[69]  J. Harper,et al.  SCFβ-TRCP Controls Clock-dependent Transcription via Casein Kinase 1-dependent Degradation of the Mammalian Period-1 (Per1) Proteinm* , 2005, Journal of Biological Chemistry.

[70]  Shai Linn,et al.  The expression of the ubiquitin ligase subunit Cks1 in human breast cancer , 2005, Breast Cancer Research.

[71]  F. Bassermann,et al.  NIPA Defines an SCF-Type Mammalian E3 Ligase that Regulates Mitotic Entry , 2005, Cell.

[72]  L. Chin,et al.  A Genetic Screen for Candidate Tumor Suppressors Identifies REST , 2005, Cell.

[73]  U. Schüller,et al.  Elevated Expression of Wnt Antagonists Is a Common Event in Hepatoblastomas , 2005, Clinical Cancer Research.

[74]  S. Desiderio,et al.  Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. , 2005, Molecular cell.

[75]  D. Germain,et al.  Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer , 2005, Oncogene.

[76]  N. Sagata,et al.  Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[77]  K. Harada,et al.  High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation. , 2005, Anticancer research.

[78]  S. Linn,et al.  The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma , 2005, Cancer.

[79]  M. Poetsch,et al.  Expression of Skp2 and p27KIP1 in naevi and malignant melanoma of the skin and its relation to clinical outcome. , 2005, Histology and histopathology.

[80]  Peter Woolf,et al.  Control of Mammalian Circadian Rhythm by CKIε-Regulated Proteasome-Mediated PER2 Degradation , 2005, Molecular and Cellular Biology.

[81]  S. Fuchs,et al.  Targeting β-Transducin Repeat–Containing Protein E3 Ubiquitin Ligase Augments the Effects of Antitumor Drugs on Breast Cancer Cells , 2005 .

[82]  Bradley P. Coe,et al.  High‐resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines , 2005, Genes, chromosomes & cancer.

[83]  R. Price,et al.  Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16 , 2005, Molecular Cancer Therapeutics.

[84]  B. Sipos,et al.  Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells. , 2005, Cancer research.

[85]  D. Tindall,et al.  Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Raymond J. Deshaies,et al.  Function and regulation of cullin–RING ubiquitin ligases , 2005, Nature Reviews Molecular Cell Biology.

[87]  B. Sipos,et al.  Increased Expression of the E 3-Ubiquitin Ligase Receptor Subunit B TRCP 1 Relates to Constitutive Nuclear Factor-K B Activation and Chemoresistance in Pancreatic Carcinoma Cells , 2005 .

[88]  Birgit Samans,et al.  Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1 , 2004 .

[89]  Takashi Takata,et al.  Role of Cks1 overexpression in oral squamous cell carcinomas: cooperation with Skp2 in promoting p27 degradation. , 2004, The American journal of pathology.

[90]  J. Inazawa,et al.  Skp2 overexpression is a p27Kip1‐independent predictor of poor prognosis in patients with biliary tract cancers , 2004, Cancer science.

[91]  K. Nakayama,et al.  Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27Kip1 at G1 phase , 2004, Nature Cell Biology.

[92]  S. Fuchs,et al.  Phosphorylation and Specific Ubiquitin Acceptor Sites Are Required for Ubiquitination and Degradation of the IFNAR1 Subunit of Type I Interferon Receptor* , 2004, Journal of Biological Chemistry.

[93]  C. Berset,et al.  The ISG15 Isopeptidase UBP43 Is Regulated by Proteolysis via the SCFSkp2 Ubiquitin Ligase* , 2004, Journal of Biological Chemistry.

[94]  M. Manns,et al.  Skp2-dependent degradation of p27kip1 is essential for cell cycle progression. , 2004, Genes & development.

[95]  C. Sheehan,et al.  Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship * , 2004, Journal of cutaneous pathology.

[96]  Timothy Cardozo,et al.  Systematic analysis and nomenclature of mammalian F-box proteins. , 2004, Genes & development.

[97]  H. Samuels,et al.  Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis , 2004, Oncogene.

[98]  L. Nie,et al.  Notch-Induced E2A Degradation Requires CHIP and Hsc70 as Novel Facilitators of Ubiquitination , 2004, Molecular and Cellular Biology.

[99]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[100]  M. Pagano,et al.  Role of F-Box Protein βTrcp1 in Mammary Gland Development and Tumorigenesis , 2004, Molecular and Cellular Biology.

[101]  S. Kameoka,et al.  Activation of REST/NRSF Target Genes in Neural Stem Cells Is Sufficient To Cause Neuronal Differentiation , 2004, Molecular and Cellular Biology.

[102]  Xuedong Liu,et al.  Ubiquitination and Proteolysis of Cancer-Derived Smad4 Mutants by SCFSkp2 , 2004, Molecular and Cellular Biology.

[103]  Timothy Cardozo,et al.  The SCF ubiquitin ligase: insights into a molecular machine , 2004, Nature Reviews Molecular Cell Biology.

[104]  S. Fuchs,et al.  Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin, and NF-κB in colorectal cancer , 2004 .

[105]  J. Rudolph,et al.  Cdc25 phosphatases and cancer. , 2004, Chemistry & biology.

[106]  A. Ciechanover,et al.  Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase Skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium. , 2004, Molecular human reproduction.

[107]  J. Inazawa,et al.  Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. , 2004, The American journal of pathology.

[108]  K. Nakayama,et al.  The Papillomavirus E7 Oncoprotein Is Ubiquitinated by UbcH7 and Cullin 1- and Skp2-Containing E3 Ligase , 2004, Journal of Virology.

[109]  A. Giordano,et al.  Frequent Loss of pRb2/p130 in Human Ovarian Carcinoma , 2004, Clinical Cancer Research.

[110]  Tohru Natsume,et al.  Skp2-mediated degradation of p27 regulates progression into mitosis. , 2004, Developmental cell.

[111]  Y. Li,et al.  Negative Regulation of Prolactin Receptor Stability and Signaling Mediated by SCFβ-TrCP E3 Ubiquitin Ligase , 2004, Molecular and Cellular Biology.

[112]  Michele Pagano,et al.  Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma , 2004, Cancer.

[113]  A. Ciechanover,et al.  Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase , 2004, Oncogene.

[114]  Hiroyuki Osada,et al.  M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[115]  M. Tsao,et al.  Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker , 2004, Clinical Cancer Research.

[116]  H. Nakamine,et al.  Cdc25A and cdc25B expression in malignant lymphoma of the thyroid: correlation with histological subtypes and cell proliferation. , 2004, International journal of molecular medicine.

[117]  H. Kuwano,et al.  Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma. , 2004, Anticancer research.

[118]  W. Taylor,et al.  Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. , 2004, Cancer cell.

[119]  R. Benarous,et al.  HIV-1 Vpu Sequesters β-Transducin Repeat-containing Protein (βTrCP) in the Cytoplasm and Provokes the Accumulation of β-Catenin and Other SCFβTrCP Substrates* , 2004, Journal of Biological Chemistry.

[120]  J. Adams,et al.  Development of the Proteasome Inhibitor Velcade™ (Bortezomib) , 2004, Cancer investigation.

[121]  A. Giordano,et al.  Frequent Loss of pRb 2 / p 130 in Human Ovarian Carcinoma , 2004 .

[122]  B. Samans,et al.  Programmed cell death protein 4 suppresses CDK 1 / cdc 2 via induction of p 21 Waf 1 / Cip 1 , 2004 .

[123]  T. Utsunomiya,et al.  Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[124]  J. Bartek,et al.  Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines , 2003, Oncogene.

[125]  Michele Pagano,et al.  Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage , 2003, Nature.

[126]  Min Xu,et al.  Notch‐induced E2A ubiquitination and degradation are controlled by MAP kinase activities , 2003, The EMBO journal.

[127]  L. Banks,et al.  Regulation of the Discs Large Tumor Suppressor by a Phosphorylation-dependent Interaction with the β-TrCP Ubiquitin Ligase Receptor* , 2003, Journal of Biological Chemistry.

[128]  K. Nakayama,et al.  Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[129]  Xiaohua Wu,et al.  The SCFSkp2 Ubiquitin Ligase Complex Interacts with the Human Replication Licensing Factor Cdt1 and Regulates Cdt1 Degradation* , 2003, Journal of Biological Chemistry.

[130]  D. Haines,et al.  CDK9 Is Constitutively Expressed throughout the Cell Cycle, and Its Steady-State Expression Is Independent of SKP2 , 2003, Molecular and Cellular Biology.

[131]  Iver Petersen,et al.  Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis , 2003, The Journal of pathology.

[132]  M. Pagano,et al.  Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase* , 2003, Journal of Biological Chemistry.

[133]  K. Nakayama,et al.  Impaired degradation of inhibitory subunit of NF-κB (IκB) and β-catenin as a result of targeted disruption of the β-TrCP1 gene , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[134]  M. Pagano,et al.  Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[135]  L. Larsson,et al.  Implication of the Ubiquitin/Proteasome System in Myc-Regulated Transcription , 2003, Cell cycle.

[136]  Michele Pagano,et al.  Control of Meiotic and Mitotic Progression by the F Box Protein β-Trcp1 In Vivo , 2003 .

[137]  K. Shigemasa,et al.  Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[138]  K. Nakayama,et al.  The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. , 2003, Molecular cell.

[139]  M. Kitagawa,et al.  High expression of Cks1 in human non-small cell lung carcinomas. , 2003, Biochemical and biophysical research communications.

[140]  Hong Sun,et al.  Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. , 2003, Cancer research.

[141]  Michele Pagano,et al.  Deregulated degradation of the cdk inhibitor p27 and malignant transformation. , 2003, Seminars in cancer biology.

[142]  N. Sonenberg,et al.  The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation , 2003, Molecular and Cellular Biology.

[143]  R. Hay,et al.  βTrCP-Mediated Proteolysis of NF-κB1 p105 Requires Phosphorylation of p105 Serines 927 and 932 , 2003, Molecular and Cellular Biology.

[144]  M. Pagano,et al.  Altered Expression of p 27 and Skp 2 Proteins in Prostate Cancer of African-American Patients 1 , 2003 .

[145]  C. Cinti,et al.  Missing expression of pRb2/p130 in human retinoblastomas is associated with reduced apoptosis and lesser differentiation. , 2002, Investigative ophthalmology & visual science.

[146]  A. Giordano,et al.  Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[147]  S. Reed,et al.  The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). , 2002, Genes & development.

[148]  A. Ariza,et al.  Over-Expression of p45SKP2 in Kaposi’s Sarcoma Correlates with Higher Tumor Stage and Extracutaneous Involvement but Is Not Directly Related to p27KIP1 Down-Regulation , 2002, Modern Pathology.

[149]  J Wade Harper,et al.  Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[150]  T. Slaga,et al.  Induction of Homologue of Slimb Ubiquitin Ligase Receptor by Mitogen Signaling* , 2002, The Journal of Biological Chemistry.

[151]  S. Ramaswamy,et al.  Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. , 2002, The Journal of clinical investigation.

[152]  Holger Schulz,et al.  The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells , 2002, BMC Cell Biology.

[153]  V. Fiano,et al.  Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot , 2002, Neuroscience Letters.

[154]  A. Fong,et al.  Genetic Evidence for the Essential Role of β-Transducin Repeat-containing Protein in the Inducible Processing of NF-κB2/p100* , 2002, The Journal of Biological Chemistry.

[155]  Kenneth Pienta,et al.  APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancers , 2002 .

[156]  J. Lukas,et al.  E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1 , 2002, Nature Cell Biology.

[157]  B. Stillman,et al.  Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. , 2002, Molecular cell.

[158]  P. Dhawan,et al.  Correction: A Novel NF-κB-inducing Kinase-MAPK Signaling Pathway Up-regulates NF-κB Activity in Melanoma Cells , 2001, The Journal of Biological Chemistry.

[159]  A. Marzo,et al.  Elevated Skp 2 Protein Expression in Human Prostate Cancer : Association with Loss of the Cyclin-dependent Kinase Inhibitor p 27 and PTEN and with Reduced Recurrence-free Survival 1 , 2002 .

[160]  J. Labbé,et al.  Interaction between Cyclin T1 and SCFSKP2 Targets CDK9 for Ubiquitination and Degradation by the Proteasome , 2001, Molecular and Cellular Biology.

[161]  S. Sato,et al.  High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. , 2001, Cancer research.

[162]  Michele Pagano,et al.  Role of the F-Box Protein Skp2 in Adhesion-Dependent Cell Cycle Progression , 2001, The Journal of cell biology.

[163]  M. Loda,et al.  Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27. , 2001, Molecular endocrinology.

[164]  M. Katoh,et al.  Expression profiles of betaTRCP1 and betaTRCP2, and mutation analysis of betaTRCP2 in gastric cancer. , 2001, International journal of oncology.

[165]  J. Mestan,et al.  Skp2 is oncogenic and overexpressed in human cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[166]  Tsonwin Hai,et al.  ATF4 Degradation Relies on a Phosphorylation-Dependent Interaction with the SCFβTrCPUbiquitin Ligase , 2001, Molecular and Cellular Biology.

[167]  C J Kemp,et al.  p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. , 2001, Experimental cell research.

[168]  H Strohmaier,et al.  A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. , 2001, Molecular cell.

[169]  Brett Larsen,et al.  The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27 , 2001, Nature Cell Biology.

[170]  M. Pagano,et al.  Role of the F-box protein Skp2 in lymphomagenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[171]  C. Cinti,et al.  Expression of cell-cycle–associated proteins pRB2/p130 and p27kip1 in vulvar squamous cell carcinomas , 2001 .

[172]  M. Loda,et al.  Role of the Cdc25A phosphatase in human breast cancer. , 2000, The Journal of clinical investigation.

[173]  G. Fuller,et al.  The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells , 2000, Nature Medicine.

[174]  K. Klempnauer,et al.  Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCFp45Skp2 pathway , 2000, Oncogene.

[175]  A. Ciechanover,et al.  SCFβ‐TrCP ubiquitin ligase‐mediated processing of NF‐κB p 105 requires phosphorylation of its C‐terminus by IκB kinase , 2000 .

[176]  M. Kitagawa,et al.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication , 2000, The EMBO journal.

[177]  E. Campo,et al.  cdc25a and the splicing variant cdc25b2, but not cdc25B1, ‐B3 or ‐C, are over‐expressed in aggressive human non‐Hodgkin's lymphomas , 2000, International journal of cancer.

[178]  M. Loda,et al.  Role of the Cdc 25 A phosphatase in human breast cancer , 2000 .

[179]  S. Elledge,et al.  A family of mammalian F-box proteins , 1999, Current Biology.

[180]  M. Vidal,et al.  Identification of a family of human F-box proteins , 1999, Current Biology.

[181]  S. Ghosh,et al.  β-TrCP Mediates the Signal-induced Ubiquitination of IκBβ* , 1999, The Journal of Biological Chemistry.

[182]  V. Soldatenkov,et al.  Inhibition of homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis. , 1999, Cancer research.

[183]  K. Nakayama,et al.  Common Pathway for the Ubiquitination of IκBα, IκBβ, and IκBε Mediated by the F-Box Protein FWD1* , 1999, The Journal of Biological Chemistry.

[184]  Michele Pagano,et al.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.

[185]  Wilhelm Krek,et al.  p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells , 1999, Nature Cell Biology.

[186]  Hong Sun,et al.  p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27 , 1999, Current Biology.

[187]  Bruce A. Yankner,et al.  β-Trcp couples β-catenin phosphorylation-degradation and regulates Xenopus axis formation , 1999 .

[188]  M. Kitagawa,et al.  An F‐box protein, FWD1, mediates ubiquitin‐dependent proteolysis of β‐catenin , 1999, The EMBO journal.

[189]  M. Scheffner,et al.  Interaction between ubiquitin–protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation , 1999, Nature Cell Biology.

[190]  Z. Ronai,et al.  Recruitment of a ROC1–CUL1 Ubiquitin Ligase by Skp1 and HOS to Catalyze the Ubiquitination of IκBα , 1999 .

[191]  M. Kitagawa,et al.  Ubiquitin-dependent degradation of I_B_ is mediated by a′ ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. , 1999 .

[192]  R. Benarous,et al.  Inducible Degradation of IκBα by the Proteasome Requires Interaction with the F-box Protein h-βTrCP* , 1999, The Journal of Biological Chemistry.

[193]  R. Benarous,et al.  The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell , 1999, Current Biology.

[194]  Zhijian J. Chen,et al.  Signal-induced ubiquitination of IκBα by the F-box protein Slimb/β-TrCP , 1999 .

[195]  Stephen J. Elledge,et al.  The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro , 1999 .

[196]  G. Lagna,et al.  Negative regulation of axis formation and Wnt signaling in Xenopus embryos by the F-box/WD40 protein βTrCP , 1999, Mechanisms of Development.

[197]  M. Pagano,et al.  The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin , 1999, Oncogene.

[198]  M. Kitagawa,et al.  Erratum: Ubiquitin-dependent degradation of IκBα is mediated by a ubiquitin ligase Skp1/Cul1/F-box protein FWD1 (Proceedings of the National Academy of Sciences of the United States America (March 30, 1999) 96:7 (3859- 3863)) , 1999 .

[199]  Andrea C. Carrano,et al.  SKP 2 is required for ubiquitin-mediated degradation of the CDK inhibitor p 27 , 1999 .

[200]  M. Mann,et al.  Identification of the receptor component of the IκBα–ubiquitin ligase , 1998, Nature.

[201]  J. Gervais,et al.  Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[202]  Y. Marikawa,et al.  β-TrCP is a negative regulator of the Wnt/β-catenin signaling pathway and dorsal axis formation in Xenopus embryos , 1998, Mechanisms of Development.

[203]  E. Montserrat,et al.  cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas. , 1998, Cancer Research.

[204]  A. Giordano,et al.  Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[205]  N. Tommerup,et al.  Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[206]  R. Kobayashi,et al.  pl9 skp1 and p45 skp2 are essential elements of the cyclin A-CDK2 S phase kinase , 1995, Cell.

[207]  L. Chiriboga,et al.  Alterations in the expression of PDCD 4 in ductal carcinoma of the breast , 2022 .